Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery

Journal of Cardiothoracic Surgery

Volumn 7, Issue 1, 2012, Pages

  Kanko, Muhip ^a   Yavuz, Sadan ^a   Duman, Can ^b   Hosten, Tulay ^a   Oner, Emin ^a   Berki, Turan ^a  

^a KOCAELI UNIVERSITY   (Turkey)

^b ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

Author keywords

Coronary artery bypass surgery; Ischemia modified albumine; Myocardial ischaemia

Indexed keywords

SERUM ALBUMIN;

ADULT; AGED; ARTICLE; BLOOD; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS;

ADULT; AGED; CORONARY ARTERY BYPASS; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; SERUM ALBUMIN;

EID: 84855373068     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-7-3     Document Type: Article

References (32)

1. Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, Branham E, Apple FS, Murakami M, Morris DL. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001, 47:464-470.
2. Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, Honda SA, Rios CN, Sugiyama CE, Ha CE. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischaemia and myocardial infarction. Clin Chem 2003, 49:581-585. 10.1373/49.4.581, 12651810.
3. Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. Reduced albumin -cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin. I Am Heart J 2001, 141:985-991.
4. Quiles J, Roy D, Gaze D, Garrido IP, Avanzas P, Sinha M, Kaski JC. Relation of ischemia-modified albumin (IMA) levels following elective angioplasty forstable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol 2003, 92:322-324. 10.1016/S0002-9149(03)00638-6, 12888145.
5. Sinha M, Roy D, Gaze D, Collinson P, Kaski JC. Role of 'ischemia modified albumin', a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004, 21:29-34. 10.1136/emj.2003.006007, 1756335, 14734370.
6. Roy D, Quiles J, Sharma R, Sinha M, Avanzas P, Gaze D, Collinson P, Carlos Kaski J. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem 2004, 50(9):1656-60. 10.1373/clinchem.2004.031690, 15265817.
7. Gunduz A, Turedi S, Mentese A, Altunayoglu V, Turan I, Karahan SC, Topbas M, Aydin M, Eraydin I, Akcan B. Ischemia-modified albumin levels in cerebrovascular accidents. Am J Emerg Med 2008, 26(8):874-8. 10.1016/j.ajem.2007.11.023, 18926343.
8. Colak T, Duman C, Bamac B, Aydin A, Ozbek A, Yildiz K, Bicer U. Ischaemia modified albumin levels folloving mild closed head trauma in the rat. Turkiye Klinikleri J Med Sci 2010, 30(4):1171-6.
9. Turedi S, Gunduz A, Mentese A, Karahan SC, Yilmaz SE, Eroglu O, Ucar U, Karaca Y, Turkmen S, Russell RM. Value of ischemia-modified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med 2007, 25(7):770-3. 10.1016/j.ajem.2006.12.013, 17870479.
10. Gunduz A, Mentese A, Turedi S, Karahan SC, Mentese U, Eroglu O, Turkmen S, Turan I, Ucar U, Russell R, Balaban F. Serum ischemia-modified albumin increases in critical lower limb ischemia. Emerg Med J 2008, 25:351-353. 10.1136/emj.2007.051292, 18499817.
11. Peacock F, Morris DL, Anwaruddin S, Christenson RH, Collinson PO, Goodacre SW, Januzzi JL, Jesse RL, Kaski JC, Kontos MC, Lefevre G, Mutrie D, Sinha MK, Uettwiller-Geiger D, Pollack CV. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 2006, 152:253-262. 10.1016/j.ahj.2005.12.024, 16875905.
12. Costa MA, Carere RG, Lichtenstein SV, Foley DP, de Valk V, Lindenboom W, Roose PC, van Geldorp TR, Macaya C, Castanon JL, Fernandez-Avilèz F, Gonzáles JH, Heyer G, Unger F, Serruys PW. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization study (ARTS). Circulation 2001, 104:2689-2693. 10.1161/hc4701.099789, 11723020.
13. Klatte K, Chaitman BR, Theroux P, Gavard JA, Stocke K, Boyce S, Bartels C, Keller B, Jessel A. Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band release. J Am Coll Cardiol 2001, 38:1070-1077. 10.1016/S0735-1097(01)01481-4, 11583884.
14. Thygesen K, Alpert JS, White HD. On behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Eur Heart J 2007, 28:2525-2538.
15. Erturk E, Cekic B, Geze S, Kosucu M, Coskun I, Eroglu A, Ulusoy H, Mentese A, Karahan C, Kerimoglu S. Comparison of the effect of propofol and N-acetyl cysteine in preventing ischaemia-reperfusion injury. Eur J Anaesthesiol 2009, 26(4):279-84. 10.1097/EJA.0b013e32831c87c7, 19401659.
16. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia: a preliminary report. J Emerg Med 2000, 19:311-315. 10.1016/S0736-4679(00)00255-9, 11074321.
17. Brener SJ, Lytle BW, Schneider JP, Ellis SG, Topol EJ. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol 2002, 40:1961-1967. 10.1016/S0735-1097(02)02538-X, 12475456.
18. Januzzi JL, Lewandrowski K, MacGillivray TE, Newell JB, Kathiresan S, Servoss SJ, Lee-Lewandrowski E. A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol 2002, 39:1518-1523. 10.1016/S0735-1097(02)01789-8, 11985917.
19. Talwalkar SS, Bon Homme M, Miller JJ, Elin RJ. Ischemia modified albumin, a marker of acute ischemic events: a pilot study. Ann Clin Lab Sci 2008, 38(2):132-7.
20. Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 2006, 92:113-114. 10.1136/hrt.2004.049643, 1861004, 16365361.
21. Collinson PO, Gaze DC. Ischaemia-modified albumin: clinical utility and pitfalls in measurement. J Clin Pathol 2008, 61(9):1025-8. 10.1136/jcp.2007.053363, 18755726.
22. Senes M, Kazan N, Coşkun O, Zengi O, Inan L, Yücel D. Oxidative and nitrosative stress in acute ischaemic stroke. Ann Clin Biochem 2007, 44(Pt 1):43-7.
23. Fransen EJ, Maessen JG, Hermens WT, Glatz JFC, Burman WA. Peri-operative tissue injury and the release of inflammatory mediators in coronary artery bypass graft patients. Cardiovascular Research 2000, 45:853-859. 10.1016/S0008-6363(99)00403-4, 10728410.
24. Dusec J, St'asek J, Tichy M, Bis J, Gregor J, Vojacek J, Masin V, Polansky P, Brtko M, Cernohorsky D. Prognostic significance of ischemia modified albumin after percutaneous coronary intervention. Clinica Chimica Acta 2006, 367:77-80.
25. Falkensammer J, Stojakovic T, Huber K, Hammerer-Lercher A, Gruber I, Scharnagl H, Fraedrich G, Santner W, Schocke M, Greiner A. Serum levels of ischemia-modified albumin in healthy volunteers after exercise-induced calf-muscle ischemia. Clin Chem Lab Med 2007, 45(4):535-40. 10.1515/CCLM.2007.087, 17439334.
26. Apple FS, Quist HE, Otto AP, Mathews WE, Murakami MM. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem 2002, 48(7):1097-100.
27. Abboud H, Labreuche J, Meseguer E, Lavallee PC, Simon O, Olivot JM, Mazighi M, Dehoux M, Benessiano J, Steg PG, Amarenco P. Ischemia-modified albumin in acute stroke. Cerebrovasc Dis 2007, 23(2-3):216-20. 10.1159/000097644, 17143006.
28. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003, 107(19):2403-5. 10.1161/01.CIR.0000072764.18315.6B, 12742986.
29. Sbarouni E, Georgiadou P, Panagiotakos D, Alivizatos PA, Voudris V. Increased ischaemia modified albumin following coronary artery bypass grafting. Biomarkers 2009, 14(1):38-42. 10.1080/13547500902730706, 19283522.
30. Siebert J, Anisimowicz L, Lango R, Rogowski J, Pawlaczyk R, Brzezinski M, Beta S, Narkiewicz M. Atrial fibrillation after coronary artery bypass grafting: does the type of procedure influence the early postoperative incidence?. Eur J Cardiothorac Surg 2001, 19(4):455-9. 10.1016/S1010-7940(01)00621-2, 11306312.
31. Bar-El Y, Adler Z, Kophit A, Kertzman V, Sawaed S, Ross A, Cohen O, Milo S. Myocardial protection in operations requiring more than 2 h of aortic cross-clamping. Eur J Cardiothorac Surg 1999, 15:271-5. 10.1016/S1010-7940(99)00025-1, 10333022.
32. Kiyici A, Mehmetoglu I, Karaoglan H, Atalay H, Solak Y, Turk S. Ischemia-modified albumin levels in patients with end-stage renal disease patients on hemodialysis: does albumin analysis method affect albumin-adjusted ischemia-modified albumin levels?. J Clin Lab Anal 2010, 24(4):273-7. 10.1002/jcla.20399, 20626021.